Biophysical analysis demonstrates that helical N17 modifications enhance huntingtin self-association and membrane binding, indicating how post-translational changes regulate toxic aggregation.
Huntington's disease is a neurodegenerative disorder associated with a polyglutamine expansion within the first exon of the huntingtin protein (HTT exon 1). This mutation results in HTT dysfunction and the production of N-terminal HTT aggregates. The dimerization of the HTT exon 1 fragment through self-association of the first 17 residues (N17) is considered the initial step in the HTT exon 1 aggregation pathway. The association of N17 with membranes has been proposed to catalyze aggregation by increasing the local concentration of exon 1, and post-translational modifications (PTMs) in N17 are known to influence membrane interaction and the aggregation rate of exon 1. To elucidate the influence of N17 PTMs on both self-association and membrane interaction, thereby gaining insight into HTT function and exon 1 aggregation, we used solution nuclear magnetic resonance and circular dichroism spectroscopies to address loss of initial methionine, subsequent acetylation, and phosphorylation of threonine and serines. Our findings indicate that modifications to N17 that enhance helicity correspond to increased self-association and membrane interaction. We then conducted X-ray crystallographic studies that led to a proposed HTT exon 1 dimerization model consistent with the association of N17 dimers. This provides insight into the impact of PTMs on HTT aggregation. The experimental methods and N17 self-association model we describe may serve as a foundation for further experiments exploring the influence of N17 PTMs on HTT function and pathogenicity.
No takes yet. Share an insight, caveat, or question.
Gallo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: